Activating mutations in the NOTCH gene indicates a poor prognosis in T‐ALL patients who can be attributed in part to the inactivation of FBXW7, which possibly synergize with NOTCH1 receptor activation. This evidence concerns the gene FBXW7 and acute lymphoblastic leukemia.